– Industry Veteran Will Contribute to IRISYS’ Growing Manufacturing Services –
San Diego, April 20, 2018 – IRISYS, LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services, today announced that Hwa-Chang (Lawrence) Wang has been appointed Director of Manufacturing. Wang brings more than 24 years of management and technical experience in the pharmaceutical industry, including expertise in scale-up, validation, and commercial product manufacturing.
“This is a very opportune time for Lawrence Wang to join IRISYS,” said Gerald Yakatan, Ph.D., Chairman, CEO and founder of the Company. “IRISYS’ growing manufacturing services include GMP, clinical supply, and specialty commercial manufacturing. Lawrence has deep experience with pharmaceutical production and technical services. In addition, he has been instrumental in coordinating departments and team activities, resulting in improved productivity and streamlined manufacturing processes for FDA-approved products.”
“I am excited to IRISYS, which has an excellent reputation as a contract manufacturing organization for clients in the U.S., China, and elsewhere,” Mr. Wang stated. I look forward to helping small and mid-sized pharmaceutical companies with their drug manufacturing needs.
Mr. Wang served in positions of increasing responsibility in the Technical Service and Production Departments at Endo/Par Pharmaceutical from 2011-2018. From 2006-2011, he contributed to the effective and efficient scale-up, validation, and launch of commercial products at Anchen Pharmaceuticals, Inc. In his previous positions at Watson Laboratories, Inc. and other companies, Wang interacted with FDA inspectors, led R&D and production teams, and played key roles as a Process Engineer and a Validation Engineer. He participated in external and internal audits, and managed manufacturing teams through successful FDA inspections.
Wang was awarded a Master of Science in Engineering Management from George Washington University in Washington, DC. He received his Bachelor of Science in Chemical Engineering degree from Tamkang University in Taiwan.
IRISYS was founded in 1996 to provide contract pharmaceutical product development and manufacturing services, specializing in formulation development, cGMP manufacturing of clinical trial materials and commercial pharmaceutical products, and strategic consulting related to the drug development process. IRISYS’ custom approach to drug development is supported by the Company’s scientific and regulatory experience in moving more than 100 drug products from discovery to clinical development and commercialization
Rosenberg Business Communications